Similar Items: Treatment outcomes of daptomycin- and vancomycin-resistant Enterococcus faecium bloodstream infection
- Outcomes and Adverse Events Among Patients with Vancomycin-Resistant Enterococcal Bloodstream Infection Treated with Daptomycin Doses Greater than 12 mg/kg
- Comparison of the Efficacy and Safety of Ceftobiprole, Vancomycin, Daptomycin, and Linezolid in the Treatment of Bloodstream Infections and Skin and Skin Structure Infections: A Network Meta-Analysis
- High-resolution molecular typing of vancomycin-resistant Enterococcus faecium from Romania and Bavaria: combining enhanced DNA microarray and next generation sequencing
- Age and body weight-adjusted infusion rate (mg/kg/h) as risk factors for vancomycin infusion reaction in patients receiving perioperative antimicrobial prophylaxis: a retrospective cohort study
- Therapeutic strategies for multi-resistant Escherichia coli in urinary tract infections—a cause for concern
- Bacteremic versus Non-Bacteremic Urinary Tract Infections: Predictors of Poor Clinical Outcome